Novel ECHS1 mutation in an Emirati neonate with severe metabolic acidosis.

Pratibha Nair, Abdul Rezzak Hamzeh, Madiha Mohamed, Ethar Mustafa Malik, Mahmoud Taleb Al-Ali, Fatma Bastaki

Journal: Metabolic brain disease 2018;31(5):1189-92

PMID: 27221955

Abstract

ECHS1 is a mitochondrial matrix enzyme that catalyzes an important step in the β-oxidation spiral of fatty acid catabolism, and individuals with mutations in the ECHS1 gene suffer from an autosomal recessive condition typified by delayed psychomotor development, mitochondrial encephalopathy, hypotonia, and cardiomyopathy. Here we report the first Arab case of ECHS1 Deficiency. The patient was born to consanguineous parents with all growth parameters being low for gestational age, and was persistently desaturated. Cord blood gas and later blood analysis showed severe metabolic acidosis. Tandem MS revealed increased levels of valine, and Leucine/Isoleucine and decreased level of Glutamine. There was also a large patent ductus arteriosus with right to left shunt and a possible small muscular ventricular septal defect. Whole Exome Sequencing revealed a novel homozygous missense mutation in the ECHS1 gene; c.842 A > G (p.Glu281Gly). In-silico analysis suggests that the residue affected by this mutation may be involved in an important functional or structural role.

Address: Centre for Arab Genomic Studies, P.O. Box 22252, Dubai, UAE. [email protected].; Centre for Arab Genomic Studies, P.O. Box 22252, Dubai, UAE.; Pediatric Department, Latifa Hospital, Dubai Health Authority, Dubai, UAE.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.